idarucizumab
Jump to navigation
Jump to search
English
[edit]Etymology
[edit]From idaru- (of unknown origin) + -ci- (“cardiovascular”) + -zumab (“humanized monoclonal antibody”).
Pronunciation
[edit]- (General American) IPA(key): /ˌaɪ.də.ɹuˈsɪz.əˌmæb/
Noun
[edit]idarucizumab (uncountable)
- (pharmacology) A monoclonal antibody designed for the reversal of anticoagulant effects of dabigatran.